• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

New genetic test for deadly Abdominal Aortic Aneurysms to be explored

Oct 31, 2025
Cardiovascular building

A new genetic test could be introduced into NHS screening pathways to target those most at risk of Abdominal Aortic Aneurysms (AAA).

The new test, developed by experts funded by the NIHR Leicester BRC, aims to make sure that those at highest risk are checked in time to get treatment and save lives. 

An AAA is a swelling in the main blood vessel in the body – the aorta – which when not treated can rupture with deadly consequences. Affecting mainly men, the chances of developing an AAA increase with age.

As there are very few warning signs for an AAA, the NHS introduced a screening programme in 2013 across the UK inviting all men over the age of 65 for an ultrasound scan.

AAA is treatable if spotted early, lowering the chances of rupture. However, by analysing a patient’s DNA, experts now know how likely they are to develop an aneurysm, especially considering other risk factors such as smoking. 

Although screening uptake is generally good, those most likely to develop an AAA are least likely to attend an appointment. Because of this, a targeted and more personal approach to screening could identify those patients most at risk, and encourage them to attend their screening appointment while helping the NHS to be more cost effective. 

Researchers at the University of Leicester are now investigating how to include these genetic tests into the screening pathway for AAA, and want to work with those who could be affected to plan how best to do this. This is being led by Professor of Vascular Surgery, Matthew Bown.

“This improvement to the screening programme could ultimately save more lives, and make sure those most at risk are being treated,” he said.

“Using genetic tests to identify those people at highest risk is one way of doing this but we don’t know what people think about these sorts of developments. We want to plan these changes to the NHS with the people who will be affected by them and this research is the first step on that journey.”

One part of this research is a new project funded by the Wellcome Trust from the University of Leicester to investigate how the public feel about introducing genetic tests to improve screening, and how the results and risks should be communicated to patients.

University researchers are currently recruiting men aged 60 – 70 years for online or in person interviews to talk about how they would feel about genetic testing being used to target AAA screening. Shopping vouchers will be offered as a ‘thank you’ for those taking the time to be interviewed. 

Professor Bown said: “This could be an excellent way for local men to be involved in research that affects them and help shape the future of AAA screening in the NHS.”

Anyone who would like to get involved can get in touch via email at cgn9@leicester.ac.uk or telephone 07722192848.

Category: Press ReleasesTag: cardiovascular, News

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}